More Than

0

customers

In

0

Key Cities

across

0

Countries in Southeast Asia

Corporate Video

Hyphens Pharma is a part of the Hyphens Group. Watch it to get a quick overview of what Hyphens Group is about.

Latest news

news

Hyphens Pharma’s Meradan® Cream Launches in Indonesia

5 December 2022 – Meradan® is a steroid cream containing 0.1% mometasone furoate and physiological lipids including ceramide found in Ceradan® cream. This formula is developed with skin barrier repair properties in mind. This is important because steroid creams are known to cause skin thinning. Therefore, Meradan® confers an advantage over typical steroid creams that were formulated without skin barrier repair properties.

Meradan® is available only through prescription by doctors including dermatologists and paediatricians. It is approved for use in skin diseases that cause inflammation and itch, such as conditions like eczema, psoriasis, and skin rash.

Click here to read our media release for more details.

Read more Read less
news

TDF® Blu Voile Sunscreen Scientifically Proven to Protect Skin Against Blue Light at Cellular Level

15 September 2022 – We are pleased to announce results of a clinical study on “The protective effect of a novel sunscreen against blue light”, published recently in the International Journal of Cosmetic Science, shows that TDF® Blu Voile Sunscreen provides 82% protection at the cellular level against the harmful effects of blue light irradiation.

TDF® Blu Voile Sunscreen also offers thorough and complete protection against UV-A/UV-B and blue light, versus conventional broad-spectrum sunscreens.(1)

Click here to read our media release for more details.

(1) Francois-Newton V, et al. Int J Cosmet Sci. 2022 Aug;44(4):464-476

Read more Read less
View more
Go top